...
首页> 外文期刊>Croatian medical journal >Evaluation of modified Yfiler amplification strategy for compromised samples.
【24h】

Evaluation of modified Yfiler amplification strategy for compromised samples.

机译:对受损样品的改良Yfiler扩增策略的评估。

获取原文
获取原文并翻译 | 示例

摘要

AIM: To characterize the data produced using a modified amplification protocol for the AmpFlSTR Yfiler PCR Amplification Kit (Applied Biosystems) and explore the potential of Y-chromosomal short tandem repeat (Y-STR) recovery from severely degraded skeletal remains encountered at the Armed Forces DNA Identification Laboratory. METHODS: Experiments were performed using two sets of Yfiler amplification parameters. One set of parameters reflected the manufacturer's recommendations. The second set of parameters included twice the recommended Taq concentration and 6 additional cycles. Recovery of authentic alleles and the incidence of drop-in alleles were assessed for 3 data sets: 8 different quantities of pristine DNA, 8 artificially-degraded samples, and 31 non-probative case samples. RESULTS: Samples tested with both protocols from all 3 data sets yielded twice as many authentic alleles under the modified parameters than under the standard parameters (62% vs 31%), with only a nominal associated increase in the occurrence of non-authentic alleles (1.36% of all alleles detected). When applied to a range of representative casework samples, the modified protocol leveraged 9 or more reproducible alleles from over half of the specimens tested. CONCLUSION: Reproducible and informative Y-STR profiles can be recovered from a broad range of degraded and inhibited skeletal remains extracts when a commercially available kit is employed under modified amplification parameters.
机译:目的:表征使用改良的AmpFlSTR Yfiler PCR扩增试剂盒(应用生物系统公司)的扩增方案产生的数据,并探索从武装部队遇到的严重降解的骨骼残留物中恢复Y染色体短串联重复(Y-STR)的潜力DNA鉴定实验室。方法:使用两组Yfiler扩增参数进行实验。一组参数反映了制造商的建议。第二组参数包括建议的Taq浓度的两倍和6个额外的循环。对3个数据集评估了真实等位基因的回收率和落入等位基因的发生率:8种不同数量的原始DNA,8种人工降解的样品和31种非证明病例。结果:使用这两种方案测试的所有3个数据集的样本在修改后的参数下产生的真实等位基因数量是标准参数下的两倍(62%比31%),而非真实等位基因的发生仅名义上相关的增加(检测到所有等位基因的1.36%)。当应用于一系列代表性的案例样本时,修改后的方案利用了来自一半以上测试样本的9个或更多个可重现的等位基因。结论:当在改良的扩增参数下使用市售试剂盒时,可从广泛的降解和抑制的骨骼残留提取物中回收可再现和有用的Y-STR图谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号